Standardisation and quality assurance

Quality assurance is an essential part of laboratory practice, both in research and clinical diagnosis. The principles and practice of quality assurance (QA) in laboratory medicine in general (1), and in clinical chemistry in particular (2) have been described elsewhere and are widely acknowledged as being a key feature of good laboratory practice. The theoretical aspects of standardisation and QA of immunoassays have been discussed in a series of papers presented at the first Bergmeyer Conference (3). This chapter focuses on practical aspects of QA that are particularly important for the immunoassayist — these include assay standardisation, (sometimes referred to as calibration) internal quality control (IQC) and external quality assessment (EQA). These activities merit careful consideration in relation to immunoassay, not only because of the widespread use of the technique, but more importantly because of the particular problems that arise from the use of biological materials as calibration standards, quality control materials and reagents, for the quantitation of structurally complex analytes. In the following discussion particular reference will be made to the uses of immunoassays in endocrinology, although the principles are broadly applicable.

[1]  P. Broughton,et al.  Provisional recommendation on quality control in clinical chemistry. Part 3. Calibration and control materials. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[2]  J O Westgard,et al.  A multi-rule Shewhart chart for quality control in clinical chemistry. , 1981, Clinical chemistry.

[3]  D. Bangham Standardization in peptide hormone immunoassays: principle and practice. , 1976, Clinical chemistry.

[4]  L. Boscato,et al.  Heterophilic antibodies: a problem for all immunoassays. , 1988, Clinical chemistry.

[5]  J O Westgard,et al.  What is the quality of quality control procedures? , 1981, Scandinavian journal of clinical and laboratory investigation.

[6]  S. Jeffcoate Efficiency and effectiveness in the endocrine laboratory , 1981 .

[7]  R. Ekins Methods and Labels in Immunoassay , 1988 .

[8]  C. Sturgeon,et al.  External quality assessment of immunoassays of peptide hormones and tumour markers: principles and practice. , 1991, Annali dell'Istituto superiore di sanita.

[9]  A. Uldall Quality assurance in clinical chemistry. , 1987, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[10]  U. Lewis Variants of growth hormone and prolactin and their posttranslational modifications. , 1984, Annual review of physiology.

[11]  G. Zucchelli,et al.  Minimizing between-kit variability in immunoassay for carcinoembryonic antigen by use of a common standard. , 1986, Clinical chemistry.

[12]  I. Hanning,et al.  Factors associated with the quality of laboratory performance in the United Kingdom external quality assessment scheme for serum growth hormone. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[13]  P. Broughton,et al.  International Federation of Clinical Chemistry. Committee on Standards. Expert Panel on Nomenclature and Principles of Quality Control in Clinical Chemistry. Approved recommendation (1978) on quality control in clinical chemistry. Part 1. General principles and terminology. , 1979 .

[14]  G. Addison,et al.  THE IMMUNORADIOMETRIC ASSAY AND RELATED TECHNIQUES , 1974 .

[15]  R. G. Gaines Das,et al.  The International Standard for Pituitary FSH: collaborative study of the Standard and of four other purified human FSH preparations of differing molecular composition by bioassays, receptor assays and different immunoassay systems. , 1989, The Journal of endocrinology.

[16]  M. Stolar,et al.  Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state. , 1985, The Journal of clinical endocrinology and metabolism.

[17]  J. Seth The External Quality Assessment of Hormone Assays , 1987 .

[18]  C G Fraser,et al.  Desirable performance standards for clinical chemistry tests. , 1983, Advances in clinical chemistry.

[19]  F MacKenzie,et al.  UK external quality assessment scheme for immunoassays in endocrinology. , 1991, Annali dell'Istituto superiore di sanita.

[20]  J. Chermann,et al.  INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT , 1985, The Lancet.